{"parse":{"title":"Therapeutic drug monitoring","pageid":739219,"revid":822716124,"text":{"*":"<div class=\"mw-parser-output\"><p><b>Therapeutic drug monitoring</b> (<b>TDM</b>) is a branch of <a href=\"/wiki/Clinical_chemistry\" title=\"Clinical chemistry\">clinical chemistry</a> and <a href=\"/wiki/Clinical_pharmacology\" title=\"Clinical pharmacology\">clinical pharmacology</a> that specializes in the measurement of <a href=\"/wiki/Medication\" title=\"Medication\">medication</a> concentrations in <a href=\"/wiki/Blood\" title=\"Blood\">blood</a>. Its main focus is on drugs with a narrow <a href=\"/wiki/Therapeutic_index#Therapeutic_window\" title=\"Therapeutic index\">therapeutic window</a>.<sup id=\"cite_ref-Clinical_Chemistry_1-0\" class=\"reference\"><a href=\"#cite_note-Clinical_Chemistry-1\">&#91;1&#93;</a></sup> TDM aims at improving patient care by  adjusting the dose of drugs for which clinical experience or clinical trials have shown it improved outcome in the general or special populations.  It can be based on <i>a priori</i> pharmacogenetic, demographic and clinical information, and/or on the <i>a posteriori</i> measurement of blood concentrations of drugs (pk/pd monitoring).<sup id=\"cite_ref-Definition_of_TDM_2-0\" class=\"reference\"><a href=\"#cite_note-Definition_of_TDM-2\">&#91;2&#93;</a></sup>\n</p><p>There are numerous variables that influence the interpretation of drug concentration data: time, route and dose of drug given, time of blood sampling, handling and storage conditions, precision and accuracy of the analytical method, validity of pharmacokinetic models and assumptions, co-medications and clinical status of the patient.<sup id=\"cite_ref-Applied_PK_and_PD_3-0\" class=\"reference\"><a href=\"#cite_note-Applied_PK_and_PD-3\">&#91;3&#93;</a></sup>\n</p><p>Many different professionals (<a href=\"/wiki/Physicians\" class=\"mw-redirect\" title=\"Physicians\">physicians</a>, clinical pharmacologists, <a href=\"/wiki/Clinical_pharmacists\" class=\"mw-redirect\" title=\"Clinical pharmacists\">clinical pharmacists</a>, <a href=\"/wiki/Nurses\" class=\"mw-redirect\" title=\"Nurses\">nurses</a>, <a href=\"/wiki/Medical_Laboratory_Scientist\" class=\"mw-redirect\" title=\"Medical Laboratory Scientist\">medical laboratory scientists</a>, etc.) are involved with the various elements of drug concentration monitoring, which is a truly multidisciplinary process. Because failure to properly carry out any one of the components can severely affect the usefulness of using drug concentrations to optimize therapy, an organized approach to the overall process is critical.<sup id=\"cite_ref-Applied_PK_and_PD_3-1\" class=\"reference\"><a href=\"#cite_note-Applied_PK_and_PD-3\">&#91;3&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#A_priori\"><span class=\"tocnumber\">1</span> <span class=\"toctext\"><i>A priori</i></span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#A_posteriori\"><span class=\"tocnumber\">2</span> <span class=\"toctext\"><i>A posteriori</i></span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Characteristics_of_drugs_subject_to_TDM\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Characteristics of drugs subject to TDM</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"A_priori\"><i>A priori</i></span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Therapeutic_drug_monitoring&amp;action=edit&amp;section=1\" title=\"Edit section: A priori\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<style data-mw-deduplicate=\"TemplateStyles:r856303468\">.mw-parser-output .templatequote{overflow:hidden;margin:1em 0;padding:0 40px}.mw-parser-output .templatequote .templatequotecite{line-height:1.5em;text-align:left;padding-left:1.6em;margin-top:0}</style><blockquote class=\"templatequote\"><p><i>A priori</i> TDM consists of determining the initial dose regimen to be given to a patient, based on clinical endpoint and  established on population [(PK/PD) ]relationships.  These relationships help to identify sub-populations of patients with different dosage requirements, by utilizing demographic data, clinical findings, clinical chemistry results.\n</p></blockquote>\n<h2><span class=\"mw-headline\" id=\"A_posteriori\"><i>A posteriori</i></span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Therapeutic_drug_monitoring&amp;action=edit&amp;section=2\" title=\"Edit section: A posteriori\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>includes pre-analytical, analytical and post-analytical phases, each with the same importance;</li>\n<li>is most often based on the specific, accurate, precise and timely determinations of the active and.or toxic forms of drugs in biological samples collected at the appropriate times in the correct containers (PK monitoring),</li></ul>\n<h2><span class=\"mw-headline\" id=\"Characteristics_of_drugs_subject_to_TDM\">Characteristics of drugs subject to TDM</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Therapeutic_drug_monitoring&amp;action=edit&amp;section=3\" title=\"Edit section: Characteristics of drugs subject to TDM\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In <a href=\"/wiki/Pharmacotherapy\" title=\"Pharmacotherapy\">pharmacotherapy</a>, many medications are used without monitoring of blood levels, as their dosage can generally be varied according to the clinical response that a patient gets to that substance. In a small group of drugs, this is impossible, as insufficient levels will lead to undertreatment or resistance, and excessive levels can lead to toxicity and tissue damage.\n</p><p>Indications for therapeutic drug monitoring include:\n</p>\n<ul><li>There is an experimentally determined relationship between plasma drug concentration and the pharmacological effect.</li>\n<li>Knowledge of the drug level influences management.</li>\n<li>There is a narrow <a href=\"/wiki/Therapeutic_window\" class=\"mw-redirect\" title=\"Therapeutic window\">therapeutic window</a>.</li>\n<li>There are potential patient <a href=\"/wiki/Compliance_(medicine)\" class=\"mw-redirect\" title=\"Compliance (medicine)\">compliance</a> problems.</li>\n<li>The drug dose cannot be optimised by clinical observation alone.</li></ul>\n<p>Examples of drugs analysed by therapeutic drug monitoring:<sup id=\"cite_ref-Clinical_Chemistry_1-1\" class=\"reference\"><a href=\"#cite_note-Clinical_Chemistry-1\">&#91;1&#93;</a></sup>\n</p>\n<ul><li><a href=\"/wiki/Aminoglycoside\" title=\"Aminoglycoside\">Aminoglycoside</a> <a href=\"/wiki/Antibiotic\" title=\"Antibiotic\">antibiotics</a> (<a href=\"/wiki/Gentamicin\" title=\"Gentamicin\">gentamicin</a>)</li>\n<li><a href=\"/wiki/Antiepileptic\" class=\"mw-redirect\" title=\"Antiepileptic\">Antiepileptics</a> (such as <a href=\"/wiki/Carbamazepine\" title=\"Carbamazepine\">carbamazepine</a>, <a href=\"/wiki/Phenytoin\" title=\"Phenytoin\">phenytoin</a> and <a href=\"/wiki/Valproic_acid\" class=\"mw-redirect\" title=\"Valproic acid\">valproic acid</a>)</li>\n<li><a href=\"/wiki/Mood_stabiliser\" class=\"mw-redirect\" title=\"Mood stabiliser\">Mood stabilisers</a>, especially <a href=\"/wiki/Lithium_citrate\" title=\"Lithium citrate\">lithium citrate</a></li>\n<li><a href=\"/wiki/Antipsychotic\" title=\"Antipsychotic\">Antipsychotics</a> (such as <a href=\"/wiki/Pimozide\" title=\"Pimozide\">pimozide</a> and <a href=\"/wiki/Clozapine\" title=\"Clozapine\">clozapine</a>)</li>\n<li><a href=\"/wiki/Biopharmaceutical\" title=\"Biopharmaceutical\">Biologic</a> <a href=\"/wiki/Monoclonal_antibody_therapy\" title=\"Monoclonal antibody therapy\">monoclonal antibody drugs</a> (such as <a href=\"/wiki/Adalimumab\" title=\"Adalimumab\">adalimumab</a>, <a href=\"/wiki/Certolizumab_pegol\" title=\"Certolizumab pegol\">certolizumab pegol</a> and <a href=\"/wiki/Infliximab\" title=\"Infliximab\">infliximab</a>)</li></ul>\n<p>Therapeutic drug monitoring can also detect poisoning with above drugs, should the suspicion arise.\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Therapeutic_drug_monitoring&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-Clinical_Chemistry-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Clinical_Chemistry_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Clinical_Chemistry_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Marshall WJ, Bangert SK. Clinical Chemistry, 6th Edition. Edinburgh, London: Mosby Elsevier. 2008. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-7234-3455-9\" title=\"Special:BookSources/978-0-7234-3455-9\">978-0-7234-3455-9</a></span>\n</li>\n<li id=\"cite_note-Definition_of_TDM-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Definition_of_TDM_2-0\">^</a></b></span> <span class=\"reference-text\">IATDMCT Executive Committee. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.iatdmct.org/index.php/publisher/articleview/frmArticleID/138/\">\"Definition of TDM\"</a>, 2004, accessed July 18, 2011.</span>\n</li>\n<li id=\"cite_note-Applied_PK_and_PD-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Applied_PK_and_PD_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Applied_PK_and_PD_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Burton ME, Shaw LM, Schentag JJ, Evans, WE. Applied Pharmacokinetics &amp; Pharmacodynamics, 4th Edition. Baltimore, Philadelphia: Lippincott Williams &amp; Wilkins. 2006. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-7817-4431-7\" title=\"Special:BookSources/978-0-7817-4431-7\">978-0-7817-4431-7</a></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Therapeutic_drug_monitoring&amp;action=edit&amp;section=5\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.iatdmct.org/\">International Association of Therapeutic Drug Monitoring and Clinical Toxicology</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1267\nCached time: 20180909222642\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.052 seconds\nReal time usage: 0.074 seconds\nPreprocessor visited node count: 580/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 2683/2097152 bytes\nTemplate argument size: 1246/2097152 bytes\nHighest expansion depth: 15/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 2444/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.005/10.000 seconds\nLua memory usage: 712 KB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   52.234      1 -total\n 78.15%   40.820      2 Template:ISBN\n 22.60%   11.805      2 Template:Catalog_lookup_link\n 18.35%    9.586      1 Template:Quote\n 11.95%    6.242      2 Template:Error-small\n  9.05%    4.729      6 Template:Yesno-no\n  5.85%    3.058      6 Template:Yesno\n  5.63%    2.940      2 Template:Main_other\n  4.57%    2.385     12 Template:Trim\n  2.55%    1.331      2 Template:Tl\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:739219-0!canonical and timestamp 20180909222642 and revision id 822716124\n -->\n</div>"},"langlinks":[{"lang":"de","url":"https://de.wikipedia.org/wiki/Drug_Monitoring","langname":"German","autonym":"Deutsch","*":"Drug Monitoring"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Suivi_th%C3%A9rapeutique_pharmacologique","langname":"French","autonym":"fran\u00e7ais","*":"Suivi th\u00e9rapeutique pharmacologique"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Monitoraggio_terapeutico_dei_farmaci","langname":"Italian","autonym":"italiano","*":"Monitoraggio terapeutico dei farmaci"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E6%B2%BB%E7%99%82%E8%96%AC%E7%89%A9%E3%83%A2%E3%83%8B%E3%82%BF%E3%83%AA%E3%83%B3%E3%82%B0","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u6cbb\u7642\u85ac\u7269\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0"},{"lang":"th","url":"https://th.wikipedia.org/wiki/%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B8%95%E0%B8%B4%E0%B8%94%E0%B8%95%E0%B8%B2%E0%B8%A1%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B8%A3%E0%B8%B1%E0%B8%81%E0%B8%A9%E0%B8%B2%E0%B8%94%E0%B9%89%E0%B8%A7%E0%B8%A2%E0%B8%A2%E0%B8%B2","langname":"Thai","autonym":"\u0e44\u0e17\u0e22","*":"\u0e01\u0e32\u0e23\u0e15\u0e34\u0e14\u0e15\u0e32\u0e21\u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e14\u0e49\u0e27\u0e22\u0e22\u0e32"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E6%B2%BB%E7%99%82%E8%97%A5%E7%89%A9%E7%9B%A3%E6%8E%A7","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u6cbb\u7642\u85e5\u7269\u76e3\u63a7"}],"categories":[{"sortkey":"Therapeutic Drug Monitoring","*":"Pharmacokinetics"},{"sortkey":"Therapeutic Drug Monitoring","*":"Pharmacy"},{"sortkey":"Therapeutic Drug Monitoring","*":"Medical_monitoring"}],"links":[{"ns":0,"exists":"","*":"Adalimumab"},{"ns":0,"exists":"","*":"Aminoglycoside"},{"ns":0,"exists":"","*":"Antibiotic"},{"ns":0,"exists":"","*":"Antiepileptic"},{"ns":0,"exists":"","*":"Antipsychotic"},{"ns":0,"exists":"","*":"Biopharmaceutical"},{"ns":0,"exists":"","*":"Blood"},{"ns":0,"exists":"","*":"Carbamazepine"},{"ns":0,"exists":"","*":"Certolizumab pegol"},{"ns":0,"exists":"","*":"Clinical chemistry"},{"ns":0,"exists":"","*":"Clinical pharmacists"},{"ns":0,"exists":"","*":"Clinical pharmacology"},{"ns":0,"exists":"","*":"Clozapine"},{"ns":0,"exists":"","*":"Compliance (medicine)"},{"ns":0,"exists":"","*":"Gentamicin"},{"ns":0,"exists":"","*":"Infliximab"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Lithium citrate"},{"ns":0,"exists":"","*":"Medical Laboratory Scientist"},{"ns":0,"exists":"","*":"Medication"},{"ns":0,"exists":"","*":"Monoclonal antibody therapy"},{"ns":0,"exists":"","*":"Mood stabiliser"},{"ns":0,"exists":"","*":"Nurses"},{"ns":0,"exists":"","*":"Pharmacotherapy"},{"ns":0,"exists":"","*":"Phenytoin"},{"ns":0,"exists":"","*":"Physicians"},{"ns":0,"exists":"","*":"Pimozide"},{"ns":0,"exists":"","*":"Therapeutic index"},{"ns":0,"exists":"","*":"Therapeutic window"},{"ns":0,"exists":"","*":"Valproic acid"}],"templates":[{"ns":10,"exists":"","*":"Template:Quote"},{"ns":10,"exists":"","*":"Template:Quote/styles.css"},{"ns":10,"exists":"","*":"Template:ISBN"},{"ns":10,"exists":"","*":"Template:Catalog lookup link"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Yesno-no"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Error-small"},{"ns":10,"exists":"","*":"Template:Tl"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Check isxn"},{"ns":828,"exists":"","*":"Module:Error"}],"images":[],"externallinks":["http://www.iatdmct.org/index.php/publisher/articleview/frmArticleID/138/","http://www.iatdmct.org/"],"sections":[{"toclevel":1,"level":"2","line":"<i>A priori</i>","number":"1","index":"1","fromtitle":"Therapeutic_drug_monitoring","byteoffset":2121,"anchor":"A_priori"},{"toclevel":1,"level":"2","line":"<i>A posteriori</i>","number":"2","index":"2","fromtitle":"Therapeutic_drug_monitoring","byteoffset":2506,"anchor":"A_posteriori"},{"toclevel":1,"level":"2","line":"Characteristics of drugs subject to TDM","number":"3","index":"3","fromtitle":"Therapeutic_drug_monitoring","byteoffset":2853,"anchor":"Characteristics_of_drugs_subject_to_TDM"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"Therapeutic_drug_monitoring","byteoffset":4297,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"5","fromtitle":"Therapeutic_drug_monitoring","byteoffset":4327,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Therapeutic drug monitoring","iwlinks":[],"properties":[{"name":"defaultsort","*":"Therapeutic Drug Monitoring"},{"name":"wikibase_item","*":"Q1261151"}]}}